Alarming! Millions of Lives at Risk: Why Pharma Refuse to Develop Antibiotics Amid Rise of Superbugs

Antimicrobial resistance (AMR) is rapidly becoming a global crisis that could claim 40 million lives by 2050. In this video, we explore why pharmaceutical companies are reluctant to develop new antibiotics despite the growing threat of superbugs. With AMR already responsible for over one million deaths annually, the situation is worsening, and without urgent action, we may soon find ourselves in a world without effective antibiotics.

#AntimicrobialResistance #Superbugs #PharmaceuticalCrisis #AMR #Antibiotics #HealthCrisis #MedicalEmergency #PublicHealth #GlobalHealth #SuperbugThreat

Also Read

US Health Officials Propose New Guidelines for STD Prevention Using Common Antibiotics :: https://www.oneindia.com/international/us-health-officials-endorse-antibiotic-as-morning-after-pill-for-std-prevention-gen-3649225.html?ref=DMDesc

Anti-malarial drug considered for COVID-19 may raise risk of heart problems, scientists say :: https://www.oneindia.com/india/anti-malarial-drug-considered-for-covid-19-may-raise-risk-of-heart-problems-3064637.html?ref=DMDesc

New superbug on a killing spree in South Africa; 6 newborns already dead :: https://www.oneindia.com/international/new-superbug-on-a-killing-spree-in-south-africa-6-newborns-already-dead-2777381.html?ref=DMDesc